SAN FRANCISCO, March 23, 2023 /PRNewswire/ — WorkRamp held its second WorkRamp LEARN summit – WorkRamp LEARN Spring 23 — where Ted Blosser, WorkRamp’s CEO & Co-founder, unveiled the Learning Cloud from WorkRamp — learning infrastructure to power Employee and Customer learning on a single…
Month: March 2023
MENLO PARK, Calif., March 23, 2023 /PRNewswire/ — Global talent solutions and business consulting firm Robert Half has promoted Susan Haseley to chief environmental, social, governance (ESG) and diversity, equity and inclusion (DEI) officer, leading enterprise strategy and programming…
CHICAGO, March 23, 2023 /PRNewswire/ — The empty capsules industry is expected to experience steady growth in the near future. This is due to the increased demand for empty capsules as a result of the growing popularity of dietary supplements and nutraceuticals. The increasing awareness…
DUBLIN, March 23, 2023 /PRNewswire/ — The “Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use, By Therapeutics Area, By Workflow, By Region, Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global…
FORT LAUDERDALE, Fla., March 23, 2023 /PRNewswire/ — Sunshine Health, the state’s largest managed care organization, and Farm Share, the state’s largest independent food relief organization, today announced they have expanded their partnership to help fight food insecurity across Florida….
Veal farmers go above and beyond as animal caretakers and stewards of the land ROME, N.Y., March 23, 2023 /PRNewswire/ — For more than a century, farmers have raised veal in the United States. Times have changed over one hundred years, but one thing remains the same – the rich tradition…
HANSIZHUANG (serplulimab) is the first anti-PD-1 mAb for the first-line treatment of small cell lung cancer (SCLC) The EC and the FDA previously granted Orphan Drug Designations (ODDs) for HANSIZHUANG in SCLC HANSIZHUANG is approved in China for microsatellite instability-high (MSI-H)…
FORT LAUDERDALE, Fla. and NEW YORK, March 23, 2023 /PRNewswire/ — NavaDerm Partners, LLC (“NavaDerm” or the “Company”), a dermatology platform and portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), announced the appointment of Gopi Natarajan to its Board of Directors….
SHANGHAI, 23 de marzo de 2023 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696.HK) ha anunciado que la Agencia Europea del Medicamento (EMA) ha validado la solicitud de su anti-PD-1 mAb HANSIZHUANG (serplulimab) de desarrollo propio, en combinación con quimioterapia (carboplatino y…
CHICAGO, March 23, 2023 /PRNewswire/ — Katten announced today that its Women’s Leadership Forum hosted former US Ambassador to Ukraine Marie Yovanovitch for a virtual fireside chat in honor of Women’s History Month, spotlighting her many contributions and accomplishments. “It was very…